サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1769929

局所医薬品の世界市場：産業分析、市場規模・シェア・成長・動向・予測 (2025年～2035年)

Topical Pharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035

出版日
ページ情報
英文 213 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
局所医薬品の世界市場：産業分析、市場規模・シェア・成長・動向・予測 (2025年～2035年)
出版日: 2025年05月05日
発行: Transparency Market Research
ページ情報: 英文 213 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

局所医薬品市場 - 分析範囲

TMRの調査レポート「世界の局所医薬品市場」は、2025年から2035年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2025年を基準年、2035年を予測年として、2019年から2035年までの世界の局所医薬品市場の収益と予測を提供します。また、2025年から2035年までの世界の局所医薬品市場の複合年間成長率（CAGR、%）も掲載しています。

当レポートは広範な調査を経て作成されています。一次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。二次調査では、主要企業の製品資料、アニュアルレポート、プレスリリース、関連資料などを参照し、局所医薬品市場を推察しました。

市場概況
市場規模（2024年） 1,826億2,000万米ドル
市場規模（2035年） 3,963億米ドル
CAGR 7.2%

当レポートでは、世界の局所医薬品市場の競合情勢について分析しています。世界の局所医薬品市場で事業を展開する主要企業が特定され、各企業がさまざまな属性でプロファイルされています。企業概要・財務状況・最新動向・SWOTが、当レポートで紹介されている世界の局所医薬品市場における各企業の属性です。

目次

第1章 序文

第2章 前提条件と分析手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界の局所医薬品市場の分析と予測（2020年～2035年）

第5章 主要洞察

  • 主要な業界イベント
  • PESTEL分析
  • ポーターのファイブフォース分析
  • 主要国/地域別の償還シナリオ
  • パイプライン分析
  • 市場のアンメットニーズ
  • 政府の取り組み

第6章 世界市場の分析と予測：製品種類別

  • イントロダクションと定義
  • 主な調査結果/動向
  • 市場予測：製品種類別（金額ベース、2020年～2035年）
    • 半固形製剤
      • クリーム
      • 軟膏・ペースト
      • ローション
      • ゲル
    • 液体製剤
      • 懸濁液
      • 溶液
    • その他
  • 市場の魅力分析：製品種類別

第7章 世界市場の分析と予測：用途別

  • イントロダクションと定義
  • 主な調査結果/動向
  • 市場予測：用途別（金額ベース、2020年～2035年）
    • 皮膚治療
    • 創傷治癒
    • 抗炎症研究
    • その他
  • 市場の魅力分析：用途別

第8章 世界市場の分析と予測：流通チャネル別

  • イントロダクションと定義
  • 主な調査結果/動向
  • 市場予測：流通チャネル別（金額ベース、2020年～2035年）
    • 病院薬局
    • 小売薬局
    • オンライン薬局
  • 市場の魅力分析：流通チャネル別

第9章 世界市場の分析と予測：地域別

  • 主な分析結果
  • 市場予測：地域別（金額ベース、2020年～2035年）
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力分析：地域別

第10章 北米市場の分析と予測

第11章 欧州市場の分析と予測

第12章 アジア太平洋市場の分析と予測

第13章 ラテンアメリカ市場の分析と予測

第14章 中東・アフリカ市場の分析と予測

第15章 競合情勢

  • 市場企業・競合マトリックス（企業の階層別・規模別）
  • 市場シェア分析：企業別（2024年）
  • 企業プロファイル
    • Bayer AG
    • Cipla
    • GSK plc
    • Johnson & Johnson Services, Inc.
    • Novartis AG
    • Bausch Health Companies Inc.
    • Hisamitsu Pharmaceuticals Co., Inc.
    • Merck KGaA
    • Glenmark Pharmaceuticals LTD.
    • MedPharm Ltd.
    • Galderma
    • Teva Pharmaceuticals
    • Boehringer Ingelheim International GmBH
    • Pfizer Inc.
図表

List of Tables

  • Table 01: Global Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Product Type, 2020 to 2035
  • Table 02: Global Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Semi-Solid Formulations, 2020 to 2035
  • Table 03: Global Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Liquid Formulations, 2020 to 2035
  • Table 04: Global Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 05: Global Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035
  • Table 06: Global Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Region, 2020 to 2035
  • Table 07: North America Topical Pharmaceuticals Market Value (US$ Bn) Forecast, by Country, 2020-2035
  • Table 08: North America Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Product Type, 2020 to 2035
  • Table 09: North America Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Semi-Solid Formulations, 2020 to 2035
  • Table 10: North America Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Liquid Formulations, 2020 to 2035
  • Table 11: North America Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 12: North America Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035
  • Table 13: Europe Topical Pharmaceuticals Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 14: Europe Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Product Type, 2020 to 2035
  • Table 15: Europe Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Semi-Solid Formulations, 2020 to 2035
  • Table 16: Europe Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Liquid Formulations, 2020 to 2035
  • Table 17: Europe Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 18: Europe Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035
  • Table 19: Asia Pacific Topical Pharmaceuticals Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 20: Asia Pacific Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Product Type, 2020 to 2035
  • Table 21: Asia Pacific Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Semi-Solid Formulations, 2020 to 2035
  • Table 22: Asia Pacific Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Liquid Formulations, 2020 to 2035
  • Table 23: Asia Pacific Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 24: Asia Pacific Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035
  • Table 25: Latin America Topical Pharmaceuticals Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 26: Latin America Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Product Type, 2020 to 2035
  • Table 27: Latin America Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Semi-Solid Formulations, 2020 to 2035
  • Table 28: Latin America Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Liquid Formulations, 2020 to 2035
  • Table 29: Latin America Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 30: Latin America Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035
  • Table 31: Middle East & Africa Topical Pharmaceuticals Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 32: Middle East and Africa Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Product Type, 2020 to 2035
  • Table 33: Middle East and Africa Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Semi-Solid Formulations, 2020 to 2035
  • Table 34: Middle East and Africa Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Liquid Formulations, 2020 to 2035
  • Table 35: Middle East and Africa Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 36: Middle East and Africa Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035

List of Figures

  • Figure 01: Global Topical Pharmaceuticals Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 02: Global Topical Pharmaceuticals Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 03: Global Topical Pharmaceuticals Market Revenue (US$ Bn), by Semi-Solid Formulations, 2020 to 2035
  • Figure 04: Global Topical Pharmaceuticals Market Revenue (US$ Bn), by Liquid Formulations, 2020 to 2035
  • Figure 05: Global Topical Pharmaceuticals Market Revenue (US$ Bn), by Others, 2020 to 2035
  • Figure 06: Global Topical Pharmaceuticals Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 07: Global Topical Pharmaceuticals Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 08: Global Topical Pharmaceuticals Market Revenue (US$ Bn), by Dermatological Treatments, 2020 to 2035
  • Figure 09: Global Topical Pharmaceuticals Market Revenue (US$ Bn), by Wound Healing, 2020 to 2035
  • Figure 10: Global Topical Pharmaceuticals Market Revenue (US$ Bn), by Anti-inflammatory Studies, 2020 to 2035
  • Figure 11: Global Topical Pharmaceuticals Market Revenue (US$ Bn), by Others, 2020 to 2035
  • Figure 12: Global Topical Pharmaceuticals Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 13: Global Topical Pharmaceuticals Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035
  • Figure 14: Global Topical Pharmaceuticals Market Revenue (US$ Bn), by Hospital Pharmacies, 2020 to 2035
  • Figure 15: Global Topical Pharmaceuticals Market Revenue (US$ Bn), by Retail Pharmacies, 2020 to 2035
  • Figure 16: Global Topical Pharmaceuticals Market Revenue (US$ Bn), by Online Pharmacies, 2020 to 2035
  • Figure 17: Global Topical Pharmaceuticals Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 18: Global Topical Pharmaceuticals Market Attractiveness Analysis, By Region, 2025 to 2035
  • Figure 19: North America Topical Pharmaceuticals Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 20: North America Topical Pharmaceuticals Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 21: North America Topical Pharmaceuticals Market Attractiveness Analysis, by Country, 2025 to 2035
  • Figure 22: North America Topical Pharmaceuticals Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 23: North America Topical Pharmaceuticals Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 24: North America Topical Pharmaceuticals Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 25: North America Topical Pharmaceuticals Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 26: North America Topical Pharmaceuticals Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 27: North America Topical Pharmaceuticals Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035
  • Figure 28: Europe Topical Pharmaceuticals Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 29: Europe Topical Pharmaceuticals Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 30: Europe Topical Pharmaceuticals Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 31: Europe Topical Pharmaceuticals Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 32: Europe Topical Pharmaceuticals Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 33: Europe Topical Pharmaceuticals Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 34: Europe Topical Pharmaceuticals Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 35: Europe Topical Pharmaceuticals Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 36: Europe Topical Pharmaceuticals Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035
  • Figure 37: Asia Pacific Topical Pharmaceuticals Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 38: Asia Pacific Topical Pharmaceuticals Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 39: Asia Pacific Topical Pharmaceuticals Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
  • Figure 40: Asia Pacific Topical Pharmaceuticals Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 41: Asia Pacific Topical Pharmaceuticals Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 42: Asia Pacific Topical Pharmaceuticals Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 43: Asia Pacific Topical Pharmaceuticals Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 44: Asia Pacific Topical Pharmaceuticals Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 45: Asia Pacific Topical Pharmaceuticals Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035
  • Figure 46: Latin America Topical Pharmaceuticals Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 47: Latin America Topical Pharmaceuticals Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 48: Latin America Topical Pharmaceuticals Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 49: Latin America Topical Pharmaceuticals Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 50: Latin America Topical Pharmaceuticals Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 51: Latin America Topical Pharmaceuticals Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 52: Latin America Topical Pharmaceuticals Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 53: Latin America Topical Pharmaceuticals Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 54: Latin America Topical Pharmaceuticals Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035
  • Figure 55: Middle East & Africa Topical Pharmaceuticals Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 56: Middle East & Africa Topical Pharmaceuticals Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 57: Middle East & Africa Topical Pharmaceuticals Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 58: Middle East and Africa Topical Pharmaceuticals Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 59: Middle East and Africa Topical Pharmaceuticals Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 60: Middle East and Africa Topical Pharmaceuticals Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 61: Middle East and Africa Topical Pharmaceuticals Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 62: Middle East and Africa Topical Pharmaceuticals Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 63: Middle East and Africa Topical Pharmaceuticals Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035
目次
Product Code: TMRGL86661

Topical Pharmaceuticals Market - Scope of Report

TMR's report on the global topical pharmaceuticals market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global topical pharmaceuticals market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global topical pharmaceuticals market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the topical pharmaceuticals market.

Market Snapshot
Market Value in 2024US$ 182.62 Bn
Market Value in 2035US$ 396.3 Bn
CAGR7.2%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global topical pharmaceuticals market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global topical pharmaceuticals market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global topical pharmaceuticals market.

The report delves into the competitive landscape of the global topical pharmaceuticals market. Key players operating in the global topical pharmaceuticals market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global topical pharmaceuticals market profiled in this report.

Key Questions Answered in Global topical pharmaceuticals Market Report:

  • What is the sales/revenue generated by topical pharmaceuticals across all regions during the forecast period?
  • What are the opportunities in the global topical pharmaceuticals market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Topical Pharmaceuticals Market - Research Objectives and Research Approach

The comprehensive report on the global topical pharmaceuticals market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global topical pharmaceuticals market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global topical pharmaceuticals market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Topical Pharmaceuticals Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Topical Pharmaceuticals Market Analysis and Forecast, 2020 to 2035
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Key Industry Events
  • 5.2. PESTEL Analysis
  • 5.3. PORTER's Five Forces Analysis
  • 5.4. Reimbursement Scenario by Key Countries/Regions
  • 5.5. Pipeline Analysis
  • 5.6. Unmet Needs of the Market
  • 5.7. Government Initiatives

6. Global Topical Pharmaceuticals Market Analysis and Forecast, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product Type, 2020 to 2035
    • 6.3.1. Semi-Solid Formulations
      • 6.3.1.1. Creams
      • 6.3.1.2. Ointments & Pastes
      • 6.3.1.3. Lotions
      • 6.3.1.4. Gel
    • 6.3.2. Liquid Formulations
      • 6.3.2.1. Suspensions
      • 6.3.2.2. Solutions
    • 6.3.3. Others
  • 6.4. Market Attractiveness Analysis, by Product Type

7. Global Topical Pharmaceuticals Market Analysis and Forecast, by Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Application, 2020 to 2035
    • 7.3.1. Dermatological Treatments
    • 7.3.2. Wound Healing
    • 7.3.3. Anti-inflammatory Studies
    • 7.3.4. Others
  • 7.4. Market Attractiveness Analysis, by Application

8. Global Topical Pharmaceuticals Market Analysis and Forecast, by Distribution Channel

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Distribution Channel, 2020 to 2035
    • 8.3.1. Hospital Pharmacies
    • 8.3.2. Retail Pharmacies
    • 8.3.3. Online Pharmacies
  • 8.4. Market Attractiveness Analysis, by Distribution Channel

9. Global Topical Pharmaceuticals Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2020 to 2035
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Topical Pharmaceuticals Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product Type, 2020 to 2035
    • 10.2.1. Semi-Solid Formulations
      • 10.2.1.1. Creams
      • 10.2.1.2. Ointments & Pastes
      • 10.2.1.3. Lotions
      • 10.2.1.4. Gel
    • 10.2.2. Liquid Formulations
      • 10.2.2.1. Suspensions
      • 10.2.2.2. Solutions
    • 10.2.3. Others
  • 10.3. Market Value Forecast, by Application, 2020 to 2035
    • 10.3.1. Dermatological Treatments
    • 10.3.2. Wound Healing
    • 10.3.3. Anti-inflammatory Studies
    • 10.3.4. Others
  • 10.4. Market Value Forecast, by Distribution Channel, 2020 to 2035
    • 10.4.1. Hospital Pharmacies
    • 10.4.2. Retail Pharmacies
    • 10.4.3. Online Pharmacies
  • 10.5. Market Value Forecast, by Country, 2020 to 2035
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product Type
    • 10.6.2. By Application
    • 10.6.3. By Distribution Channel
    • 10.6.4. By Country

11. Europe Topical Pharmaceuticals Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product Type, 2020 to 2035
    • 11.2.1. Semi-Solid Formulations
      • 11.2.1.1. Creams
      • 11.2.1.2. Ointments & Pastes
      • 11.2.1.3. Lotions
      • 11.2.1.4. Gel
    • 11.2.2. Liquid Formulations
      • 11.2.2.1. Suspensions
      • 11.2.2.2. Solutions
    • 11.2.3. Others
  • 11.3. Market Value Forecast, by Application, 2020 to 2035
    • 11.3.1. Dermatological Treatments
    • 11.3.2. Wound Healing
    • 11.3.3. Anti-inflammatory Studies
    • 11.3.4. Others
  • 11.4. Market Value Forecast, by Distribution Channel, 2020 to 2035
    • 11.4.1. Hospital Pharmacies
    • 11.4.2. Retail Pharmacies
    • 11.4.3. Online Pharmacies
  • 11.5. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 11.5.1. Germany
    • 11.5.2. UK
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Product Type
    • 11.6.2. By Application
    • 11.6.3. By Distribution Channel
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Topical Pharmaceuticals Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product Type, 2020 to 2035
    • 12.2.1. Semi-Solid Formulations
      • 12.2.1.1. Creams
      • 12.2.1.2. Ointments & Pastes
      • 12.2.1.3. Lotions
      • 12.2.1.4. Gel
    • 12.2.2. Liquid Formulations
      • 12.2.2.1. Suspensions
      • 12.2.2.2. Solutions
    • 12.2.3. Others
  • 12.3. Market Value Forecast, by Application, 2020 to 2035
    • 12.3.1. Dermatological Treatments
    • 12.3.2. Wound Healing
    • 12.3.3. Anti-inflammatory Studies
    • 12.3.4. Others
  • 12.4. Market Value Forecast, by Distribution Channel, 2020 to 2035
    • 12.4.1. Hospital Pharmacies
    • 12.4.2. Retail Pharmacies
    • 12.4.3. Online Pharmacies
  • 12.5. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product Type
    • 12.6.2. By Application
    • 12.6.3. By Distribution Channel
    • 12.6.4. By Country/Sub-region

13. Latin America Topical Pharmaceuticals Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product Type, 2020 to 2035
    • 13.2.1. Semi-Solid Formulations
      • 13.2.1.1. Creams
      • 13.2.1.2. Ointments & Pastes
      • 13.2.1.3. Lotions
      • 13.2.1.4. Gel
    • 13.2.2. Liquid Formulations
      • 13.2.2.1. Suspensions
      • 13.2.2.2. Solutions
    • 13.2.3. Others
  • 13.3. Market Value Forecast, by Application, 2020 to 2035
    • 13.3.1. Dermatological Treatments
    • 13.3.2. Wound Healing
    • 13.3.3. Anti-inflammatory Studies
    • 13.3.4. Others
  • 13.4. Market Value Forecast, by Distribution Channel, 2020 to 2035
    • 13.4.1. Hospital Pharmacies
    • 13.4.2. Retail Pharmacies
    • 13.4.3. Online Pharmacies
  • 13.5. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Product Type
    • 13.6.2. By Application
    • 13.6.3. By Distribution Channel
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Topical Pharmaceuticals Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product Type, 2020 to 2035
    • 14.2.1. Semi-Solid Formulations
      • 14.2.1.1. Creams
      • 14.2.1.2. Ointments & Pastes
      • 14.2.1.3. Lotions
      • 14.2.1.4. Gel
    • 14.2.2. Liquid Formulations
      • 14.2.2.1. Suspensions
      • 14.2.2.2. Solutions
    • 14.2.3. Others
  • 14.3. Market Value Forecast, by Application, 2020 to 2035
    • 14.3.1. Dermatological Treatments
    • 14.3.2. Wound Healing
    • 14.3.3. Anti-inflammatory Studies
    • 14.3.4. Others
  • 14.4. Market Value Forecast, by Distribution Channel, 2020 to 2035
    • 14.4.1. Hospital Pharmacies
    • 14.4.2. Retail Pharmacies
    • 14.4.3. Online Pharmacies
  • 14.5. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Product Type
    • 14.6.2. By Application
    • 14.6.3. By Distribution Channel
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis, by Company (2024)
  • 15.3. Company Profiles
    • 15.3.1. Bayer AG
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Product Portfolio
      • 15.3.1.4. Business Strategies
      • 15.3.1.5. Recent Developments
    • 15.3.2. Cipla
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Product Portfolio
      • 15.3.2.4. Business Strategies
      • 15.3.2.5. Recent Developments
    • 15.3.3. GSK plc
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Product Portfolio
      • 15.3.3.4. Business Strategies
      • 15.3.3.5. Recent Developments
    • 15.3.4. Johnson & Johnson Services, Inc.
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Product Portfolio
      • 15.3.4.4. Business Strategies
      • 15.3.4.5. Recent Developments
    • 15.3.5. Novartis AG
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Product Portfolio
      • 15.3.5.4. Business Strategies
      • 15.3.5.5. Recent Developments
    • 15.3.6. Bausch Health Companies Inc.
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Product Portfolio
      • 15.3.6.4. Business Strategies
      • 15.3.6.5. Recent Developments
    • 15.3.7. Hisamitsu Pharmaceuticals Co., Inc.
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Product Portfolio
      • 15.3.7.4. Business Strategies
      • 15.3.7.5. Recent Developments
    • 15.3.8. Merck KGaA
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Product Portfolio
      • 15.3.8.4. Business Strategies
      • 15.3.8.5. Recent Developments
    • 15.3.9. Glenmark Pharmaceuticals LTD.
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Product Portfolio
      • 15.3.9.4. Business Strategies
      • 15.3.9.5. Recent Developments
    • 15.3.10. MedPharm Ltd.
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Financial Overview
      • 15.3.10.3. Product Portfolio
      • 15.3.10.4. Business Strategies
      • 15.3.10.5. Recent Developments
    • 15.3.11. Galderma
      • 15.3.11.1. Company Overview
      • 15.3.11.2. Financial Overview
      • 15.3.11.3. Product Portfolio
      • 15.3.11.4. Business Strategies
      • 15.3.11.5. Recent Developments
    • 15.3.12. Teva Pharmaceuticals
      • 15.3.12.1. Company Overview
      • 15.3.12.2. Financial Overview
      • 15.3.12.3. Product Portfolio
      • 15.3.12.4. Business Strategies
      • 15.3.12.5. Recent Developments
    • 15.3.13. Boehringer Ingelheim International GmBH
      • 15.3.13.1. Company Overview
      • 15.3.13.2. Financial Overview
      • 15.3.13.3. Product Portfolio
      • 15.3.13.4. Business Strategies
      • 15.3.13.5. Recent Developments
    • 15.3.14. Pfizer Inc.
      • 15.3.14.1. Company Overview
      • 15.3.14.2. Financial Overview
      • 15.3.14.3. Product Portfolio
      • 15.3.14.4. Business Strategies
      • 15.3.14.5. Recent Developments